Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: results from the LEADER and SUSTAIN 6 clinical trials

S Verma, SC Bain, JB Honore… - Diabetes, Obesity …, 2020 - Wiley Online Library
The randomized, double‐blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …
被引用次数：15 相关文章
[HTML] nih.gov

[HTML][HTML] Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials

S Verma, SC Bain, JB Honoré, JFE Mann… - Diabetes, Obesity & …, 2020 - ncbi.nlm.nih.gov
The randomized, double-blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.

S Verma, SC Bain, JB Honoré… - Diabetes, Obesity & …, 2020 - europepmc.org
The randomized, double‐blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …
[PDF] archive.org

[PDF][PDF] Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials

scholar.archive.org
The randomized, double-blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials

S Verma, SC Bain, JB Honoré, JFE Mann, MA Nauck… - 2020 - pubmed.ncbi.nlm.nih.gov
The randomized, double-blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.

S Verma, SC Bain, JB Honoré… - Diabetes, Obesity & …, 2020 - search.ebscohost.com
The randomized, double-blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …

Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials

S Verma, SC Bain, JB Honoré, JFE Mann… - Diabetes, Obesity and …, 2020 - cdr.lib.unc.edu
The randomized, double-blind, cardiovascular outcomes trials LEADER (NCT01179048)
and SUSTAIN 6 (NCT01720446) showed cardiovascular risk reduction in patients with type …